Advanced search
Publication Cover
Cancer Management and Research Volume 9, 2017 - Issue
Submit an article Journal homepage
148
Views
3
CrossRef citations to date
0
Altmetric
Review

Prospect of the use of checkpoint inhibitors in hepatocellular cancer treatments

Ali RaufiDivision of Hematology/Oncology, Department of Medicine, Joan C. Edwards School of Medicine at Marshall University, Edward Comprehensive Care Center, Huntington, WV, USACorrespondence[email protected]
&
Maria Tria TironaDivision of Hematology/Oncology, Department of Medicine, Joan C. Edwards School of Medicine at Marshall University, Edward Comprehensive Care Center, Huntington, WV, USA
Pages 19-27 | Published online: 09 Feb 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zhuo Chen, Zhengkui Jiang, Wenzhou Zhang & Baoxia He. (2018) Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib. Cancer Management and Research 10, pages 3057-3067.
Read now
Yanli Wang & Zigui Tang. (2018) A novel long-sustaining system of apatinib for long-term inhibition of the proliferation of hepatocellular carcinoma cells. OncoTargets and Therapy 11, pages 8529-8541.
Read now
Jiaqi Li, Jing Zhao, Huan Wang, Xiaohan Li, Aixia Liu, Qin Qin & Boan Li. (2018) MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor. OncoTargets and Therapy 11, pages 5885-5894.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.